← ClinicoQ
EAU · 2024

Renal Colic (Urolithiasis) — Management Guideline

Source: EAU Guidelines on Urolithiasis, European Association of Urology, 2024
Guideline: Strong Guideline: Conditional Guideline: Not recommended ClinicoQ pathway suggestion (not from the cited guideline)

Diagnosis

Diagnostic criteria Suspected based on acute flank pain radiating to the groin, often with nausea/vomiting and hematuria; confirmed by imaging showing a ureteral or renal stone.
⚠ Alarm features (investigate before diagnosing)
Initial workup
TestWhen to order
Ultrasound First-line imaging — avoids radiation, safe and reproducible.
Non-contrast low-dose CT When ultrasound is inconclusive, or stone characterization is needed.
Urinalysis + urine culture In all patients, to assess for infection and hematuria.

Treatment

Acute pain management

1 NSAID (e.g., diclofenac) Strong (Guideline recommendation) — first-line over opioids
Dose
Diclofenac sodium 100–150 mg/day (oral or suppository, in divided doses); IM dosing may be used for immediate acute pain relief in the emergency setting
Duration
3–10 days
Evidence level
High
Avoid if
Significant renal impairment, active GI bleeding, cardiovascular disease
If no response ClinicoQ pathway
Add an opioid if pain remains uncontrolled; avoid pethidine specifically if an opioid is needed

Facilitating stone passage (medical expulsive therapy)

1 Alpha-blocker (e.g., tamsulosin) Conditional (Guideline recommendation) — supporting evidence described as conflicting
Dose
0.4 mg once daily
Duration
Until stone passage, typically up to 4 weeks
Evidence level
Conflicting/Low
Avoid if
Symptomatic hypotension; known hypersensitivity
If no response ClinicoQ pathway
If analgesia and expulsive therapy fail, proceed to decompression or stone removal

When medical management fails

1 Urgent decompression (stenting or percutaneous nephrostomy) or stone removal Strong (Guideline recommendation) — mandatory if sepsis or analgesia-refractory pain
Dose
Duration
Urgent
Evidence level
High
Avoid if
If no response

✕ Treatments the guideline advises against

Pethidine (as the opioid of choice): Guideline specifically advises against pethidine if an opioid is needed — associated with a higher rate of vomiting than other options.
⚠️ This is an educational summary of current international clinical practice guidelines and does not replace individualized clinical judgment. Final treatment decisions remain the responsibility of the treating physician.